Annual Total Assets
$4.37 M
-$2.27 M-34.21%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual total assets is $4.37 million, with the most recent change of -$2.27 million (-34.21%) on December 31, 2022.
- During the last 3 years, NAVB annual total assets has risen by +$220.70 thousand (+5.32%).
- NAVB annual total assets is now -93.16% below its all-time high of $63.90 million, reached on December 31, 1996.
Performance
NAVB Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$5.70 M
-$2.52 M-30.67%
September 30, 2023
Summary
- As of February 8, 2025, NAVB quarterly total assets is $5.70 million, with the most recent change of -$2.52 million (-30.67%) on September 30, 2023.
- Over the past year, NAVB quarterly total assets has dropped by -$2.52 million (-30.67%).
- NAVB quarterly total assets is now -91.08% below its all-time high of $63.90 million, reached on December 31, 1996.
Performance
NAVB Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
NAVB Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.2% | -30.7% |
| 3 y3 years | +5.3% | -30.7% |
| 5 y5 years | -79.0% | -30.7% |
NAVB Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.2% | at low | -30.7% | +140.7% |
| 5 y | 5-year | -43.6% | +5.3% | -49.5% | +140.7% |
| alltime | all time | -93.2% | +5.3% | -91.1% | +140.7% |
Navidea Biopharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $5.70 M(-30.7%) |
| Jun 2023 | - | $8.22 M(+247.2%) |
| Mar 2023 | - | $2.37 M(-45.8%) |
| Dec 2022 | $4.37 M(-34.2%) | $4.37 M(-30.1%) |
| Sep 2022 | - | $6.26 M(+150.0%) |
| Jun 2022 | - | $2.50 M(-30.5%) |
| Mar 2022 | - | $3.60 M(-45.8%) |
| Dec 2021 | $6.64 M(-14.3%) | $6.64 M(-25.8%) |
| Sep 2021 | - | $8.96 M(-20.6%) |
| Jun 2021 | - | $11.28 M(+11.9%) |
| Mar 2021 | - | $10.08 M(+29.9%) |
| Dec 2020 | $7.76 M(+86.9%) | $7.76 M(+29.4%) |
| Sep 2020 | - | $6.00 M(-15.6%) |
| Jun 2020 | - | $7.11 M(+58.7%) |
| Mar 2020 | - | $4.48 M(+7.9%) |
| Dec 2019 | $4.15 M(-40.9%) | $4.15 M(-13.9%) |
| Sep 2019 | - | $4.82 M(-40.7%) |
| Jun 2019 | - | $8.13 M(+63.9%) |
| Mar 2019 | - | $4.96 M(-29.4%) |
| Dec 2018 | $7.02 M(-66.2%) | $7.02 M(-22.9%) |
| Sep 2018 | - | $9.11 M(+5.2%) |
| Jun 2018 | - | $8.66 M(-52.7%) |
| Mar 2018 | - | $18.32 M(-11.8%) |
| Dec 2017 | $20.78 M(+66.8%) | $20.78 M(-8.1%) |
| Sep 2017 | - | $22.61 M(-12.7%) |
| Jun 2017 | - | $25.90 M(-21.3%) |
| Mar 2017 | - | $32.93 M(+164.2%) |
| Dec 2016 | $12.46 M(-16.7%) | $12.46 M(+11.4%) |
| Sep 2016 | - | $11.19 M(+28.9%) |
| Jun 2016 | - | $8.68 M(-29.3%) |
| Mar 2016 | - | $12.28 M(-17.9%) |
| Dec 2015 | $14.96 M(+26.5%) | $14.96 M(-14.4%) |
| Sep 2015 | - | $17.48 M(-21.2%) |
| Jun 2015 | - | $22.20 M(+103.3%) |
| Mar 2015 | - | $10.92 M(-7.7%) |
| Dec 2014 | $11.83 M(-70.7%) | $11.83 M(-32.9%) |
| Sep 2014 | - | $17.64 M(-25.2%) |
| Jun 2014 | - | $23.59 M(-27.7%) |
| Mar 2014 | - | $32.64 M(-19.0%) |
| Dec 2013 | $40.32 M(+236.7%) | $40.32 M(-19.3%) |
| Sep 2013 | - | $49.94 M(+60.5%) |
| Jun 2013 | - | $31.12 M(+128.7%) |
| Mar 2013 | - | $13.61 M(+13.6%) |
| Dec 2012 | $11.97 M(-61.6%) | $11.97 M(-12.0%) |
| Sep 2012 | - | $13.61 M(-32.0%) |
| Jun 2012 | - | $20.01 M(-19.1%) |
| Mar 2012 | - | $24.73 M(-20.7%) |
| Dec 2011 | $31.19 M(+187.2%) | $31.19 M(-6.5%) |
| Sep 2011 | - | $33.37 M(+178.4%) |
| Jun 2011 | - | $11.99 M(-13.6%) |
| Mar 2011 | - | $13.87 M(+27.7%) |
| Dec 2010 | $10.86 M(+20.5%) | $10.86 M(+55.5%) |
| Sep 2010 | - | $6.99 M(-11.5%) |
| Jun 2010 | - | $7.89 M(-14.8%) |
| Mar 2010 | - | $9.26 M(+2.7%) |
| Dec 2009 | $9.02 M(-6.3%) | $9.02 M(-2.1%) |
| Sep 2009 | - | $9.21 M(+13.4%) |
| Jun 2009 | - | $8.13 M(-10.4%) |
| Mar 2009 | - | $9.07 M(-5.7%) |
| Dec 2008 | $9.62 M | $9.62 M(+30.9%) |
| Sep 2008 | - | $7.35 M(-13.1%) |
| Jun 2008 | - | $8.46 M(+33.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $6.36 M(-10.0%) |
| Dec 2007 | $7.06 M(-12.1%) | $7.06 M(+16.7%) |
| Sep 2007 | - | $6.05 M(-0.5%) |
| Jun 2007 | - | $6.08 M(-11.2%) |
| Mar 2007 | - | $6.85 M(-14.7%) |
| Dec 2006 | $8.03 M(-30.6%) | $8.03 M(-2.9%) |
| Sep 2006 | - | $8.27 M(-13.9%) |
| Jun 2006 | - | $9.61 M(-8.9%) |
| Mar 2006 | - | $10.54 M(-8.9%) |
| Dec 2005 | $11.57 M(-24.7%) | $11.57 M(-5.8%) |
| Sep 2005 | - | $12.28 M(-10.2%) |
| Jun 2005 | - | $13.68 M(-7.1%) |
| Mar 2005 | - | $14.72 M(-4.2%) |
| Dec 2004 | $15.37 M(+108.1%) | $15.37 M(+93.0%) |
| Sep 2004 | - | $7.96 M(-5.7%) |
| Jun 2004 | - | $8.44 M(-3.6%) |
| Mar 2004 | - | $8.76 M(+18.6%) |
| Dec 2003 | $7.38 M(+4.3%) | $7.38 M(+12.4%) |
| Sep 2003 | - | $6.57 M(-4.4%) |
| Jun 2003 | - | $6.88 M(+6.8%) |
| Mar 2003 | - | $6.44 M(-9.1%) |
| Dec 2002 | $7.08 M(-37.5%) | $7.08 M(-24.4%) |
| Sep 2002 | - | $9.37 M(-5.8%) |
| Jun 2002 | - | $9.95 M(+0.1%) |
| Mar 2002 | - | $9.94 M(-12.2%) |
| Dec 2001 | $11.33 M(+49.6%) | $11.33 M(+45.2%) |
| Sep 2001 | - | $7.80 M(+10.3%) |
| Jun 2001 | - | $7.07 M(+0.6%) |
| Mar 2001 | - | $7.04 M(-7.1%) |
| Dec 2000 | $7.57 M(-26.6%) | $7.57 M(+16.5%) |
| Sep 2000 | - | $6.50 M(-11.0%) |
| Jun 2000 | - | $7.31 M(+10.8%) |
| Mar 2000 | - | $6.60 M(-35.3%) |
| Dec 1999 | $10.32 M(-13.9%) | - |
| Jun 1999 | - | $10.20 M(-15.0%) |
| Mar 1999 | - | $12.00 M(+0.0%) |
| Dec 1998 | $11.99 M(-71.1%) | $11.99 M(-49.2%) |
| Sep 1998 | - | $23.60 M(-20.8%) |
| Jun 1998 | - | $29.80 M(-17.5%) |
| Mar 1998 | - | $36.10 M(-13.2%) |
| Dec 1997 | $41.57 M(-34.9%) | $41.57 M(-13.7%) |
| Sep 1997 | - | $48.20 M(-8.9%) |
| Jun 1997 | - | $52.90 M(-8.0%) |
| Mar 1997 | - | $57.50 M(-10.0%) |
| Dec 1996 | $63.90 M(+165.1%) | $63.90 M(+20.3%) |
| Sep 1996 | - | $53.10 M(-0.4%) |
| Jun 1996 | - | $53.30 M(+129.7%) |
| Mar 1996 | - | $23.20 M(-3.7%) |
| Dec 1995 | $24.10 M(0.0%) | $24.10 M(+2.1%) |
| Sep 1995 | - | $23.60 M(+29.0%) |
| Jun 1995 | - | $18.30 M(+66.4%) |
| Mar 1995 | - | $11.00 M(-54.4%) |
| Dec 1994 | $24.10 M(+91.3%) | $24.10 M(+136.3%) |
| Sep 1994 | - | $10.20 M(+20.0%) |
| Jun 1994 | - | $8.50 M(-22.0%) |
| Mar 1994 | - | $10.90 M(-13.5%) |
| Dec 1993 | $12.60 M(-3.1%) | $12.60 M(+51.8%) |
| Sep 1993 | - | $8.30 M(-14.4%) |
| Jun 1993 | - | $9.70 M(-16.4%) |
| Mar 1993 | - | $11.60 M(-10.8%) |
| Dec 1992 | $13.00 M | $13.00 M(+140.7%) |
| Sep 1992 | - | $5.40 M |
FAQ
- What is Navidea Biopharmaceuticals annual total assets?
- What is the all time high annual total assets for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual total assets year-on-year change?
- What is Navidea Biopharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly total assets year-on-year change?
What is Navidea Biopharmaceuticals annual total assets?
The current annual total assets of NAVB is $4.37 M
What is the all time high annual total assets for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual total assets is $63.90 M
What is Navidea Biopharmaceuticals annual total assets year-on-year change?
Over the past year, NAVB annual total assets has changed by -$2.27 M (-34.21%)
What is Navidea Biopharmaceuticals quarterly total assets?
The current quarterly total assets of NAVB is $5.70 M
What is the all time high quarterly total assets for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly total assets is $63.90 M
What is Navidea Biopharmaceuticals quarterly total assets year-on-year change?
Over the past year, NAVB quarterly total assets has changed by -$2.52 M (-30.67%)